share_log

Possible Bearish Signals With Quaker Chemical Insiders Disposing Stock

Possible Bearish Signals With Quaker Chemical Insiders Disposing Stock

Quaker Chemical內部人士正在出售股票,可能存在消極信號
Simply Wall St ·  12/02 23:16

A number of Quaker Chemical Corporation (NYSE:KWR) insiders sold their shares in the last year, which may have raised concerns among investors. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

在過去一年中,許多康寶化學公司(紐交所:KWR)的內部人士賣出了他們的股票,這可能引起了投資者的擔憂。在分析內部交易時,了解內部人士是否在買入要比了解他們是否在賣出更有價值,因爲後者傳達了一個模棱兩可的信息。然而,當多個內部人士在特定期間內出售股票時,股東應該留意,因爲這可能是一個警告信號。

While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.

雖然在長期投資方面內部交易並非最重要的事情,但完全忽略內部交易是愚蠢的。

Quaker Chemical Insider Transactions Over The Last Year

過去一年來康寶化學公司內部交易

In fact, the recent sale by David Slinkman was the biggest sale of Quaker Chemical shares made by an insider individual in the last twelve months, according to our records. So we know that an insider sold shares at around the present share price of US$158. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.

事實上,根據我們的記錄,大衛·斯林克曼最近的股票出售是過去十二個月中內部個人在康寶化學公司所作的最大交易。因此,我們知道一位內部人士以大約每股158美元的現價出售了股票。雖然內部人士的出售是一個負面因素,但對我們來說,如果股票是以較低價格出售則更爲負面。考慮到交易發生在當前價格附近,這使我們有些謹慎,但並不是一個主要問題。

Insiders in Quaker Chemical didn't buy any shares in the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

康寶化學公司的內部人士在過去一年中沒有買入任何股票。您可以查看下面圖表中過去一年來公司和個人的內部交易情況。如果您想準確了解誰以多少價格何時出售,請點擊下方的圖形!

big
NYSE:KWR Insider Trading Volume December 2nd 2024
紐交所:KWR 內部交易成交量 2024年12月2日

For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.

對於那些喜歡發現潛力股票的人,可以免費查看最新內部交易股票的小盤公司名單,這可能正是您要找的機會。

Quaker Chemical Insiders Are Selling The Stock

Quaker Chemical 內部人士正在出售該股

The last three months saw significant insider selling at Quaker Chemical. In total, Senior VP & CTO David Slinkman sold US$285k worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.

過去三個月,Quaker Chemical 發生了大量內部賣出交易。總體而言,高級副總裁兼首席技術官David Slinkman 在那段時間內以價值28.5萬美元的股票,而我們完全沒有記錄任何購買。總體來說,這讓我們有些謹慎,但這並非是一切的終點。

Insider Ownership Of Quaker Chemical

Quaker Chemical 內部人士對該公司的所有權

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. Quaker Chemical insiders own about US$27m worth of shares. That equates to 0.9% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

另一種測試公司領導人和其他股東之間關係的方式是查看他們擁有的股份數量。我認爲,如果公司內部人士擁有大量股份,這是一個好跡象。Quaker Chemical的內部人士持有價值約2700萬美元的股份。這相當於公司的0.9%。這種內部人士持股水平良好,但尚未達到特別突出的水平。這確實表明了相當程度的一致性。

So What Does This Data Suggest About Quaker Chemical Insiders?

那麼,這些數據對Quaker Chemical內部人士有什麼暗示呢?

An insider sold stock recently, but they haven't been buying. Looking to the last twelve months, our data doesn't show any insider buying. But since Quaker Chemical is profitable and growing, we're not too worried by this. Insiders own shares, but we're still pretty cautious, given the history of sales. So we'd only buy after careful consideration. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. At Simply Wall St, we found 1 warning sign for Quaker Chemical that deserve your attention before buying any shares.

最近一位內部人士出售了股票,但他們並沒有進行買入操作。回顧過去十二個月,我們的數據沒有顯示任何內部人士購買情況。但由於Quaker Chemical盈利且增長,我們對此並不太擔憂。內部人士持有股份,但鑑於賣出歷史,我們仍然相當謹慎。因此,只有經過慎重考慮後,我們才會購買。所以這些內部交易可以幫助我們建立關於該股票的投資論點,但了解這家公司面臨的風險也是值得的。在Simply Wall St,我們發現了Quaker Chemical的1個警示信號,值得在購買股份之前引起您的關注。

Of course Quaker Chemical may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然,Quaker Chemical可能並非最佳的股票購買選擇。因此,您可能希望查看這些高質量公司的免費集合。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論